Evidence map›Paper›PMID 21975349›Full record

ArticleClinical pharmacology and therapeutics2011

Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome.

J Mestres, S A Seifert, T I Oprea

Abstract read
In one paragraph

Article in Clinical pharmacology and therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Myxobacteria: natural pharmaceutical factories.Microbial cell factories · 2012
    Article
  15. Of possible cheminformatics futures.Journal of computer-aided molecular design · 2012
    Article
  16. Article
  17. Drug Repurposing from an Academic Perspective.Drug discovery today. Therapeutic strategies · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

J MestresChemogenomics Laboratory, IMIM-Hospital del Mar and University Pompeu Fabra, Barcelona, Spain.
S A Seifert
T I Oprea
Biocom · USPompeu Fabra University · ESUniversity of New Mexico · US

Funding

Yeast Biology ConsortiumU54MH084690 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI TEGOS, GEORGE P · 2008 to 2013
$14.4M
Chemical Pattern Detection and Visualization in Biological NetworksR21GM095952 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI OPREA, TUDOR I · 2011 to 2012
$415k
NIGMS NIH HHS 1R21GM095952-01NIGMS NIH HHS R21 GM095952NIMH NIH HHS 5U54MH084690-03NIMH NIH HHS U54 MH084690PHS HHS HHSN-271-2008-00025-C
6 · The paper itself

Abstract

The link between cyclobenzaprine (Flexeril) administration and serotonin syndrome (SS) is subject to debate. Establishing such a connection is difficult because of the limited number of case reports available and the almost complete ignorance of its preclinical pharmacology. In this context, evidence is provided here that cyclobenzaprine blocks the serotonin and norepinephrine transporters and binds to another set of five serotonin receptors. SS should be considered when indicative signs occur in the context of cyclobenzaprine use.

Indexed as

AmitriptylineAntidepressive Agents, TricyclicHumansNorepinephrine Plasma Membrane Transport ProteinsProtein BindingReceptors, SerotoninSerotonin Plasma Membrane Transport ProteinsSerotonin SyndromeAmitriptylineAntidepressive Agents, TricycliccyclobenzaprineNorepinephrine Plasma Membrane Transport ProteinsReceptors, SerotoninSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID21975349
PMCPMC3809033
OpenAlexW2026545457

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.